Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥234.19 Million ≈ $34.27 Million USD) by net assets (CN¥6.97 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Guizhou Xinbang Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Guizhou Xinbang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002390 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CoAsia Microelectronics
TWO:8096
|
-0.504x |
|
Hunan Jiudian Pharmaceutical Co Ltd
SHE:300705
|
0.068x |
|
Forward Industries Inc
NASDAQ:FORD
|
-0.002x |
|
SeAH Bestee
KO:001430
|
0.007x |
|
Shenzhen Fuanna Bedding and Furnishing Co Ltd
SHE:002327
|
0.030x |
|
Kvutzat Acro Ltd.
TA:ACRO
|
-0.030x |
|
China Railway Signal & Communication Corporation Limited
F:RS3
|
0.008x |
|
Salfacorp
SN:SALFACORP
|
0.128x |
Annual Cash Flow Conversion Efficiency for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Guizhou Xinbang Pharmaceutical Co Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.02 Billion ≈ $1.03 Billion |
CN¥634.97 Million ≈ $92.92 Million |
0.090x | -18.29% |
| 2023-12-31 | CN¥7.14 Billion ≈ $1.05 Billion |
CN¥790.62 Million ≈ $115.69 Million |
0.111x | +32.38% |
| 2022-12-31 | CN¥7.07 Billion ≈ $1.03 Billion |
CN¥590.80 Million ≈ $86.45 Million |
0.084x | +24.68% |
| 2021-12-31 | CN¥6.83 Billion ≈ $999.22 Million |
CN¥457.97 Million ≈ $67.02 Million |
0.067x | -53.29% |
| 2020-12-31 | CN¥5.17 Billion ≈ $756.31 Million |
CN¥742.11 Million ≈ $108.59 Million |
0.144x | -18.22% |
| 2019-12-31 | CN¥5.05 Billion ≈ $738.73 Million |
CN¥886.33 Million ≈ $129.70 Million |
0.176x | +515.18% |
| 2018-12-31 | CN¥5.17 Billion ≈ $756.32 Million |
CN¥-218.56 Million ≈ $-31.98 Million |
-0.042x | -241.67% |
| 2017-12-31 | CN¥6.76 Billion ≈ $989.00 Million |
CN¥201.74 Million ≈ $29.52 Million |
0.030x | +197.48% |
| 2016-12-31 | CN¥6.49 Billion ≈ $948.96 Million |
CN¥-198.59 Million ≈ $-29.06 Million |
-0.031x | -137.59% |
| 2015-12-31 | CN¥2.67 Billion ≈ $390.56 Million |
CN¥217.40 Million ≈ $31.81 Million |
0.081x | +200.81% |
| 2014-12-31 | CN¥2.46 Billion ≈ $359.67 Million |
CN¥-198.60 Million ≈ $-29.06 Million |
-0.081x | -292.27% |
| 2013-12-31 | CN¥1.04 Billion ≈ $151.59 Million |
CN¥-21.34 Million ≈ $-3.12 Million |
-0.021x | +42.23% |
| 2012-12-31 | CN¥1.02 Billion ≈ $149.64 Million |
CN¥-36.46 Million ≈ $-5.34 Million |
-0.036x | +12.39% |
| 2011-12-31 | CN¥979.53 Million ≈ $143.34 Million |
CN¥-39.87 Million ≈ $-5.83 Million |
-0.041x | -1661.76% |
| 2010-12-31 | CN¥959.70 Million ≈ $140.43 Million |
CN¥2.50 Million ≈ $365.97K |
0.003x | -98.42% |
| 2009-12-31 | CN¥252.83 Million ≈ $37.00 Million |
CN¥41.75 Million ≈ $6.11 Million |
0.165x | +37.96% |
| 2008-12-31 | CN¥207.69 Million ≈ $30.39 Million |
CN¥24.86 Million ≈ $3.64 Million |
0.120x | -35.86% |
| 2007-12-31 | CN¥174.08 Million ≈ $25.47 Million |
CN¥32.49 Million ≈ $4.75 Million |
0.187x | +266.24% |
| 2006-12-31 | CN¥144.17 Million ≈ $21.10 Million |
CN¥7.35 Million ≈ $1.07 Million |
0.051x | -- |
About Guizhou Xinbang Pharmaceutical Co Ltd
Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological m… Read more